We design and install the go-to-market strategy, channel infrastructure, and revenue architecture that takes a diagnostic platform from clearance to commercial traction.
Architect go-to-market sequencing, pricing logic, and clinical utility mapping for the 0-to-1 commercialization window. Focus areas include go-to-market strategy, pricing architecture anchored to workflow economics, and clinical utility mapping for buyer procurement confidence.
Prioritize regulatory sequencing and reimbursement alignment to compress time from clearance to contracted clinical use. Focus areas include regulatory sequencing, reimbursement alignment, and channel access optimization.
Install execution systems that sustain adoption velocity from pilot placement through national distribution. Focus areas include ROI modeling, pitch optimization, and early revenue execution.
AdvisoryDx operates in a single vertical. Every engagement, framework, and deliverable is purpose built for the regulatory, reimbursement, and commercial dynamics of the in vitro diagnostics market.
Market Entry Strategy, Pricing Optimization Model, Product Launch Blueprint, National Distribution Roadmap, Competitive Positioning Brief, Sales Enablement Program.
Translated regulatory progress into adoption momentum by sequencing evidence milestones, building clinical utility positioning for formulary discussions, and installing revenue infrastructure before national expansion.
Scaled decentralized testing adoption by identifying early sites with the strongest workflow fit, engineering go-to-market sequencing for rapid first contracts, and deploying sales infrastructure that sustained post-launch velocity.
Diagnose commercialization risk and issue a prioritized architecture brief.
Build full commercialization architecture for launch readiness and disciplined execution.
Direct access to 25 years of IVD leadership and 12 years of early stage diagnostic scaling.